Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
Condition(s):AsthmaLast Updated:February 1, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):AsthmaLast Updated:February 1, 2024Recruiting
Condition(s):Prurigo NodularisLast Updated:February 22, 2024Recruiting
Condition(s):Chronic Spontaneous UrticariaLast Updated:February 1, 2024Recruiting
Condition(s):Dermatitis AtopicLast Updated:January 26, 2024Recruiting
Condition(s):Atopic DermatitisLast Updated:December 14, 2023Recruiting
Condition(s):Prurigo NodularisLast Updated:March 5, 2024Not yet recruiting
Condition(s):Prurigo NodularisLast Updated:February 29, 2024Recruiting
Condition(s):Wheezing; AsthmaLast Updated:March 12, 2024Recruiting
Condition(s):Chronic Rhinosinusitis With Nasal Polyps; AsthmaLast Updated:February 15, 2024Recruiting
Condition(s):Bullous PemphigoidLast Updated:October 6, 2023Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.